These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15034103)

  • 1. Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study.
    Okubo K; Ikewaki K; Sakai S; Tada N; Kawaguchi Y; Mochizuki S
    J Am Soc Nephrol; 2004 Apr; 15(4):1008-15. PubMed ID: 15034103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).
    Tilly-Kiesi M; Lichtenstein AH; Ordovas JM; Dolnikowski G; Malmström R; Taskinen MR; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):873-80. PubMed ID: 9157950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.
    Velez-Carrasco W; Lichtenstein AH; Li Z; Dolnikowski GG; Lamon-Fava S; Welty FK; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):801-6. PubMed ID: 10712406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.
    De Oliveira E Silva ER; Foster D; McGee Harper M; Seidman CE; Smith JD; Breslow JL; Brinton EA
    Circulation; 2000 Nov; 102(19):2347-52. PubMed ID: 11067787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.
    Ikewaki K; Rader DJ; Sakamoto T; Nishiwaki M; Wakimoto N; Schaefer JR; Ishikawa T; Fairwell T; Zech LA; Nakamura H
    J Clin Invest; 1993 Oct; 92(4):1650-8. PubMed ID: 8408618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
    Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
    Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
    Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
    Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method.
    Ikewaki K; Zech LA; Brewer HB; Rader DJ
    J Lipid Res; 1996 Feb; 37(2):399-407. PubMed ID: 9026537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.
    Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
    Atherosclerosis; 2000 Sep; 152(1):229-37. PubMed ID: 10996359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
    Pietzsch J; Julius U; Nitzsche S; Hanefeld M
    Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.
    Dugi KA; Amar MJ; Haudenschild CC; Shamburek RD; Bensadoun A; Hoyt RF; Fruchart-Najib J; Madj Z; Brewer HB; Santamarina-Fojo S
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):793-800. PubMed ID: 10712405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of HDL deficiency in mice overexpressing human apoA-II.
    Julve J; Escolà-Gil JC; Ribas V; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL; Blanco-Vaca F
    J Lipid Res; 2002 Oct; 43(10):1734-42. PubMed ID: 12364558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
    Millar JS; Duffy D; Gadi R; Bloedon LT; Dunbar RL; Wolfe ML; Movva R; Shah A; Fuki IV; McCoy M; Harris CJ; Wang MD; Howey DC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):140-6. PubMed ID: 18988892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
    Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
    Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
    Brousseau ME; Diffenderfer MR; Millar JS; Nartsupha C; Asztalos BF; Welty FK; Wolfe ML; Rudling M; Björkhem I; Angelin B; Mancuso JP; Digenio AG; Rader DJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1057-64. PubMed ID: 15761191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.